Extendicare (EXE) Dividend Yield, Date & History C$10.02 -0.10 (-0.99%) (As of 05:28 PM ET) Add Compare Share Share Dividend Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Extendicare Dividend SummaryDividend Yield4.79%Annual DividendC$0.48Recent Dividend Payment Nov. 15 Dividend Payout Ratio 70.59% Extendicare (EXE) pays an annual dividend of C$0.48 per share, with a dividend yield of 4.79%. The next payment of C$0.04 per share was paid on Friday, November 15, to investors who owned the stock before the ex-dividend date of Thursday, October 31. The company currently pays out 70.59% of its earnings and 15.34% of its cash flow as dividends. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryEXE Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Extendicare's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Extendicare in Dividend Calculator EXE Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Extendicare's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Extendicare in Dividend Yield Calculator Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Extendicare vs. The CompetitionCompare Extendicare's annual dividend, yield, and 3-year growth rate with averages for Medical and TSE companies to evaluate its performance against the market.TypeExtendicareMedical CompaniesTSE CompaniesAnnual DividendC$0.48C$0.06C$1.06Dividend Yield4.79%4.81%5.75%Extendicare Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings70.59%Based on This Year's Estimate78.24%Based on Cashflow15.34% Extendicare Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date10/15/2024Monthly$0.04 - 5.25%10/31/202410/31/202411/15/20249/16/2024Monthly$0.04 - 5.17%9/27/20249/30/202410/15/20248/12/2024Monthly$0.04 - 5.9%8/30/20248/30/20249/16/2024 Get the Latest News and Ratings for EXE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024Monthly$0.04 - 6.63%7/31/20247/31/20248/15/20246/17/2024Monthly$0.04 - 6.54%6/28/20246/28/20247/15/20245/15/2024Monthly$0.04 - 6.59%5/31/20245/31/20246/17/20244/15/2024Monthly$0.04 - 6.55%4/29/20244/30/20245/15/20243/7/2024Monthly$0.04 - 6.68%3/27/20243/29/20244/15/20242/15/2024Monthly$0.04 - 6.85%2/28/20242/29/20243/15/20241/15/2024Monthly$0.04 - 6.53%1/30/20241/31/20242/15/202412/15/2023Monthly$0.04 - 6.58%12/28/202312/29/20231/15/202411/9/2023Monthly$0.04 - 7.88%11/29/202311/30/202312/15/202310/16/2023Monthly$0.04 - 7.74%10/30/202310/31/202311/15/20239/15/2023Monthly$0.04 - 7.68%9/28/20239/29/202310/16/20238/30/2023Monthly$0.04 - 6.77%8/30/20239/15/20239/15/20237/17/2023Monthly$0.04 - 6.35%7/28/20237/31/20238/15/20236/15/2023Monthly$0.04 - 6.64%6/29/20236/30/20237/17/20235/4/2023Monthly$0.04 - 7.09%5/30/20235/31/20236/15/20234/17/2023Monthly$0.04 - 7.34%4/27/20234/28/20235/15/20233/15/2023Monthly$0.04 - 7.68%3/30/20233/31/20234/17/2023Did You See Trump’s Bombshell Exec. Order 001? (Ad)Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. 2/15/2023Monthly$0.04 - 7.17%2/27/20232/28/20233/15/20231/16/2023Monthly$0.04 - 7.09%1/30/20231/31/20232/15/2023This table shows Extendicare's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Extendicare Dividend - Frequently Asked Questions What is Extendicare's dividend yield? The current dividend yield for Extendicare is 4.79%. Learn more on EXE's dividend yield history. How much is Extendicare's annual dividend? The annual dividend for EXE shares is C$0.48. Learn more on EXE's annual dividend history. How often does Extendicare pay dividends? Extendicare pays monthly dividends to shareholders. When was Extendicare's most recent dividend payment? Extendicare's most recent monthly dividend payment of C$0.04 per share was made to shareholders on Friday, November 15, 2024. When was Extendicare's most recent ex-dividend date? Extendicare's most recent ex-dividend date was Thursday, October 31, 2024. When did Extendicare last increase or decrease its dividend? The most recent change in the company's dividend was an increase of C$0.01 on Monday, July 17, 2017. What is Extendicare's dividend payout ratio? The dividend payout ratio for EXE is: 70.59% based on the trailing year of earnings 78.24% based on this year's estimates 15.34% based on cash flow Is Extendicare a good dividend stock? Extendicare's dividend yield of 5.14% is higher than the average Medical company that issues a dividend. Extendicare's dividend payout ratio of 70.59% is at a healthy, sustainable level, below 75% of its earnings. Looking at the stock as a whole, market analysts rate Extendicare stock as a Hold, forecasting limited upside or downside, with the stock seen as fairly valued at this time. More Dividend Resources from MarketBeat Related Companies Sienna Senior Living Dividend Yield Medical Facilities Dividend Yield Neighbourly Pharmacy Dividend Yield Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Latest Articles Medtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond3 Best Dividend Stocks to Buy as Interest Rates FallIntuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy3 High-Yield Dividend Stocks for Income Now and Growth LaterDividend King ABM Industries is on Track for New HighsWhy Altria Stock is Still a Good Dividend PlayGet Paid While You Wait - OneMain's Juicy DividendsAlphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead More Dividend News Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. This page (TSE:EXE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXE Stock Alerts